The hybrid Alzheimer’s Association International Conference was held July 26th-30th 2021 in Denver, CO and online.

World leading basic scientists, clinical researchers, clinicians and the care research community came together to share the latest research discoveries in the diagnosis, prevention, treatment, and management of Alzheimer’s disease.

VJDementia brings you exclusive content on the greatest scientific and clinical developments from the meeting! Explore below…

AAIC 2021

AAIC 2021

The hybrid Alzheimer’s Association International Conference was held July 26th-30th 2021 in Denver, CO and online.

World leading basic scientists, clinical researchers, clinicians and the care research community came together to share the latest research discoveries in the diagnosis, prevention, treatment, and management of Alzheimer’s disease.

VJDementia brings you exclusive content on the greatest scientific and clinical developments from the meeting! Explore below…

Endothelial biomarkers for vascular contributions to dementia 3:17
Endothelial biomarkers for vascular contributions to dementia
Atticus Hainsworth • 4 Aug 2021
Contextual disadvantage as a major independent factor in brain health disparities 4:29
Contextual disadvantage as a major independent factor in brain health disparities
Amy Kind • 2 Aug 2021
COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesis 3:10
COR388: a novel approach to treating Alzheimer’s based on the gingipain hypothesis
Michael Detke • 28 Jul 2021
The importance of new methods for monitoring tau pathology 3:36
The importance of new methods for monitoring tau pathology
Alexis Moscoso Rial • 28 Jul 2021
Investigating novel plasma-based P-tau biomarkers 1:32
Investigating novel plasma-based P-tau biomarkers
Nicholas Ashton • 30 Jul 2021
Diagnosing dementia in low educated and indigenous populations 18:42
Diagnosing dementia in low educated and indigenous populations
Ricardo Nitrini • 23 Jul 2021
Understanding brain health disparities 1:12
Understanding brain health disparities
Amy Kind • 2 Aug 2021
The ability of plasma P-tau231 to detect preclinical Alzheimer’s disease 2:20
The ability of plasma P-tau231 to detect preclinical Alzheimer’s disease
Nicholas Ashton • 30 Jul 2021
The exposome: a rapidly emerging field 1:32
The exposome: a rapidly emerging field
Amy Kind • 2 Aug 2021
Targeting P. gingivalis infection to treat Alzheimer’s: the evidence 10:20
Targeting P. gingivalis infection to treat Alzheimer’s: the evidence
Michael Detke • 28 Jul 2021
Association of CSF and plasma biomarkers with longitudinal tau accumulation 2:51
Association of CSF and plasma biomarkers with longitudinal tau accumulation
Alexis Moscoso Rial • 28 Jul 2021
Phase II/III GAIN trial of a novel lysine-gingipain inhibitor for the treatment of Alzheimer’s 2:46
Phase II/III GAIN trial of a novel lysine-gingipain inhibitor for the treatment of Alzheimer’s
Michael Detke • 28 Jul 2021
The content of VJDementia is intended for healthcare professionals